Print This Page Email This Page Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More R&D Monsanto, Evogene Team Up for Stress-Resistant GenesCalifornia Advances Ban on PFOA in Food PackagingChemtura Declares Force Majeure Due to Butadiene ShortagesIndia Approves Policy to Encourage Urea InvestmentsMitsui Develops Novel Catalysts Related Stories Major Report Forecasts Growth in Pharma OutsourcingCambrex Closes New Jersey SiteDuPont Licenses Syngenta's New Insect-Resistant CornIndustrial Biotechnology: Aiming to Compete on Price and Performance Congress Passes ‘Veto Proof’ Farm Bill

EnviroTech :: R&D

June 23, 2008

Wacker Signs Licensing Deal with Xoma

Deepti Ramesh

Wacker Biotech (Jena, Germany), a subsidiary of Wacker Chemie, says it has signed a licensing agreement with biopharmaceutical company Xoma (Berkeley, CA), to use Xoma’s bacterial cell expression technology for R&D. The agreement allows Wacker...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers